Arlington Capital invests in injectable drugs maker Afton Scientific
Tom Thorpe, founder and CEO of Afton, will continue to lead the company and remain a material shareholder going forward.
Tom Thorpe, founder and CEO of Afton, will continue to lead the company and remain a material shareholder going forward.
Copyright PEI Media
Not for publication, email or dissemination